Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vaxart, Inc

0.4700
-0.0005-0.11%
Pre-market: 0.52610.0561+11.94%05:02 EST
Volume:1.28M
Turnover:606.89K
Market Cap:106.92M
PE:-1.17
High:0.4901
Open:0.4722
Low:0.4650
Close:0.4705
Loading ...

Vaxart announces norovirus vaccine candidate trial data published

TIPRANKS
·
13 hours ago

Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults

GlobeNewswire
·
14 hours ago

Vaxart Inc - Project Agreement Stop Work Order in Effect for 90 Days

THOMSON REUTERS
·
24 Feb

Vaxart - on Feb 21, Received Stop Work Orders From Advanced Technology International for Project Agreement No. 01

THOMSON REUTERS
·
24 Feb

Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors

THOMSON REUTERS
·
28 Jan

Vaxart Appoints Seasoned Biotech Executive Kevin Finney to Board of Directors

GlobeNewswire
·
28 Jan

Oppenheimer Sticks to Their Buy Rating for Vaxart (VXRT)

TIPRANKS
·
14 Jan

Vaxart Says Oral Covid-19 Vaccine Candidate Recommended for Continued Study

MT Newswires Live
·
14 Jan

Vaxart Announces Favorable Dsmb Review of Sentinel Cohort From Covid-19 Phase 2B Clinical Trial

THOMSON REUTERS
·
14 Jan

Sector Update: Health Care Stocks Lower in Late Afternoon Trading

MT Newswires Live
·
28 Dec 2024

Top Midday Gainers

MT Newswires Live
·
28 Dec 2024

Vaxart Gets Increased Funding for COVID-19 Pill Vaccine Study

MT Newswires Live
·
28 Dec 2024

Vaxart project agreement change ups funding for oral COVID vaccine candidate

TIPRANKS
·
27 Dec 2024

Vaxart - Funding Ceiling Increased to About $460.7 Million; Funding for Trial Increased to About $134.2 Million

THOMSON REUTERS
·
27 Dec 2024

Vaxart Inc - Enters Into Modification No. 4 to Project Agreement With Advanced Technology International

THOMSON REUTERS
·
27 Dec 2024

Vaxart Completes Sentinel Cohort Enrollment in Phase 2b COVID-19 Vaccine Trial

MT Newswires Live
·
03 Dec 2024